FMR CORP 13D and 13G filings for Tempest Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Tempest Therapeutics, Inc. TPST |
FMR CORP | 431,932 2.244% |
-215,966 (-33.33%) |
Filing |
| 2021-07-06 10:59 am Purchase |
2021-07-02 | 13G | Tempest Therapeutics, Inc. TPST |
FMR CORP | 647,898 9.764% |
647,898 (New Position) |
Filing |